Management of dyslipidemia for cardiovascular disease risk reduction: Synopsis of the 2014 U.S. ... Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease.
The correct answer is B. Cardiovascular disease. This content is available to MKSAP 19 subscribers as Question 19 in the Rheumatology section. ... More information about MKSAP is available online. The most appropriate assessment to perform is for
Waist circumference is important when considering risks such as cardiovascular disease, diabetes, and cancer.
or cardiovascular disease events compared with those who continued aspirin, but the findings of the post hoc analysis were inconclusive. ... Although aspirin cessation was not associated with any secondary outcome, it appeared to increase cardiovascular
He has hypertension. Family history does not include cardiovascular disease in any first-degree relatives. ... The most appropriate test to establish a diagnosis of coronary artery disease (CAD) in this patient is an exercise treadmill stress test.
the primary prevention of cardiovascular disease in adults ages 60 years or older and says use should be an individual decision in patients ages 40 to 59 years. ... In the new draft recommendation, the USPSTF recommends that the decision to begin
In the trials, patients at the highest risk for atherosclerotic cardiovascular disease events (acute coronary syndrome, myocardial infarction, stroke, angina, peripheral artery disease, or coronary revascularization) gained the most benefit from
75 years despite their higher incidence of atherosclerotic cardiovascular disease. ... Patients older than age 75 years were less likely than younger patients to receive moderate- or high-intensity statins, regardless of atherosclerotic cardiovascular
By 2003, at least one-third of American adults ages 35 and older, as well as 4 out of every 5 with cardiovascular disease, were taking aspirin daily or every other ... Frequency and practice-level variation in inappropriate aspirin use for the primary
The patient's 10-year risk for atherosclerotic cardiovascular disease is 15.7%. In addition to therapeutic lifestyle changes, which of the following is the most appropriate treatment? ... risk assessment for primary prevention of atherosclerotic